Cardea Bio
A manufacturer of graphene-based biosensors being used to monitor biological systems using semiconductors.
Launch date
Employees
Market cap
-
Enterprise valuation
€24—35m (Dealroom.co estimates Jan 2021.)
San Diego California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | Grant | |
| N/A | $1.1m | Seed | |
$7.8m | Series A | ||
$7.5m Valuation: $39.0m | Series A | ||
$6.5m | Series A | ||
* | $1.1m | Grant | |
* | N/A | Acquisition | |
| Total Funding | €21.8m | ||
Related Content
Recent News about Cardea Bio
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.